Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial
National Cancer Institute (NCI)
National Cancer Institute (NCI)
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
National Cancer Institute (NCI)
AstraZeneca
All India Institute of Medical Sciences, Bhubaneswar
Stanford University
PMV Pharmaceuticals, Inc
Mayo Clinic
Kivu Bioscience Inc.
Alterome Therapeutics, Inc.
Eli Lilly and Company
Eli Lilly and Company
ViroMissile, Inc.
Eli Lilly and Company
AstraZeneca
West German Study Group
Institut Curie
Tizona Therapeutics, Inc
Essen Biotech
Essen Biotech
Clasp Therapeutics, Inc.
Eli Lilly and Company
Angiex, Inc.
NiKang Therapeutics, Inc.
Ottawa Hospital Research Institute
MacroGenics
Nanjing Sanhome Pharmaceutical, Co., Ltd.
ALX Oncology Inc.
General Oncology, Inc.
DualityBio Inc.
Eli Lilly and Company
Kidney Cancer Research Bureau
Dartmouth-Hitchcock Medical Center
NRG Oncology
BriaCell Therapeutics Corporation
OncoNano Medicine, Inc.
MOMA Therapeutics
GlaxoSmithKline
Institut Curie
Memorial Sloan Kettering Cancer Center
Dartmouth-Hitchcock Medical Center
Novartis
Institut Bergonié
Hadassah Medical Organization
Sichuan Baili Pharmaceutical Co., Ltd.
Incyclix Bio
Nurix Therapeutics, Inc.
Hangzhou SynRx Therapeutics Biomedical Technology Co., Ltd
Yunnan Cancer Hospital
Memgen, Inc.